Literature DB >> 16282646

Disseminated and chronic Lyme borreliosis in Norway, 1995 - 2004.

K Nygård1, A Broch Brantsaeter, R Mehl.   

Abstract

Lyme borreliosis is the most common tickborne infection in Norway. All clinical manifestations of Lyme borreliosis other than erythema migrans are notifiable to Folkehelseinstituttet, the Norwegian Institute of Public Health. During the period 1995-2004 a total of 1506 cases of disseminated and chronic Lyme borreliosis were reported. Serological tests were the basis for laboratory diagnosis in almost all cases. The annual numbers of cases showed no clear trend over the period, but varied each year between 120 and 253 cases, with the highest number of cases reported in 2004. Seventy five per cent of cases with information on time of onset were in patients who fell ill during the months of June to October. There was marked geographical variation in reported incidence rates, with the highest rates reported from coastal counties in southern and central Norway. Fifty six per cent of the cases were in males and 44% in females. The highest incidence rate was found in children aged between 5 and 9 years. Neuroborreliosis was the most common clinical manifestation (71%), followed by arthritis/arthralgia (22%) and acrodermatitis chronica atrophicans (5%). Forty six per cent of patients were admitted to hospital. Prevention of borreliosis in Norway relies on measures to prevent tick bites, such as use of protective clothing and insect repellents, and early detection and removal of ticks. Antibiotics are generally not recommended for prophylaxis after tick bites in Norway.

Entities:  

Mesh:

Year:  2005        PMID: 16282646

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  7 in total

Review 1.  Emerging zoonoses and vector-borne infections affecting humans in Europe.

Authors:  R M Vorou; V G Papavassiliou; S Tsiodras
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

2.  General practitioner reported incidence of Lyme carditis in the Netherlands.

Authors:  A Hofhuis; S M Arend; C J Davids; R Tukkie; W van Pelt
Journal:  Neth Heart J       Date:  2015-11       Impact factor: 2.380

3.  Are the current notification criteria for Lyme borreliosis in Norway suitable? Results of an evaluation of Lyme borreliosis surveillance in Norway, 1995-2013.

Authors:  Emily MacDonald; Didrik Frimann Vestrheim; Richard A White; Kirstin Konsmo; Heidi Lange; Audun Aase; Karin Nygård; Pawel Stefanoff; Ingeborg Aaberge; Line Vold
Journal:  BMC Public Health       Date:  2016-08-05       Impact factor: 3.295

4.  Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice.

Authors:  Knut Eirik Eliassen; Reidar Hjetland; Harald Reiso; Morten Lindbæk; Hedda Tschudi-Madsen
Journal:  Scand J Prim Health Care       Date:  2017-02-28       Impact factor: 2.581

5.  Acrodermatitis chronica atrophicans: various faces of the late form of Lyme borreliosis.

Authors:  Anna Moniuszko-Malinowska; Piotr Czupryna; Justyna Dunaj; Sławomir Pancewicz; Adam Garkowski; Maciej Kondrusik; Sambor Grygorczuk; Joanna Zajkowska
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

6.  Lyme arthritis in Southern Norway--an endemic area for Lyme borreliosis.

Authors:  Glenn Haugeberg; Inger Johanne W Hansen; Tone Skarpaas; Sølvi Noraas; Vivian Kjelland
Journal:  BMC Infect Dis       Date:  2014-04-05       Impact factor: 3.090

7.  Gender Differences in Childhood Lyme Neuroborreliosis.

Authors:  Dag Tveitnes; Knut Øymar
Journal:  Behav Neurol       Date:  2015-10-20       Impact factor: 3.342

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.